Qualigen Therapeutics Inc... (QLGN)
NASDAQ: QLGN
· Real-Time Price · USD
1.89
0.13 (7.14%)
At close: Aug 15, 2025, 3:59 PM
1.91
1.06%
After-hours: Aug 15, 2025, 06:37 PM EDT
Qualigen Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 7.94M | 9.57M | 11.18M | 12.57M | 6.07M | 5.87M | 4.98M | 5.07M | 4.79M | 4.48M | 5.65M | 5.28M | 4.96M | 4.75M |
Cost of Revenue | 754.29K | 1.12M | 1.12M | 6.71M | 6.97M | 7.87M | 8.97M | 4.66M | 4.74M | 4.3M | 4.43M | 4.14M | 3.96M | 4.33M | 5.87M | 5.8M | 5.69M |
Gross Profit | -754.29K | -1.12M | -1.12M | 1.23M | 2.6M | 3.3M | 3.6M | 1.41M | 1.13M | 680.8K | 648.04K | 646.95K | 517.4K | 1.32M | -590.58K | -836.28K | -941.45K |
Operating Income | -7.07M | -5.75M | -6.7M | -8.21M | -10.02M | -12.3M | -10.08M | -11.69M | -12.28M | -13.59M | -18.18M | -18.61M | -21.86M | -22.66M | -22.25M | -21.16M | -16.33M |
Interest Income | 241.75K | 128.79K | 48.08K | n/a | n/a | n/a | n/a | 4.63K | 9.46K | 15.76K | 15.76K | 17.93K | 25.83K | 19.52K | 29.56K | 22.76K | 10.04K |
Pretax Income | -6.77M | -6.16M | -7.78M | -9.22M | -11.28M | -13.52M | -19.85M | -20.68M | -21.25M | -21.3M | -18.55M | -17.36M | -18.54M | -17.89M | -4.69M | -9.94M | -23.22M |
Net Income | -6.87M | -6.26M | -7.87M | -9.73M | -11.62M | -13.7M | -19.76M | -19.93M | -20.59M | -20.8M | -18.33M | -17.37M | -18.54M | -17.9M | -4.69M | -9.95M | -23.22M |
Selling & General & Admin | 5.64M | 4.2M | 4.14M | 4.33M | 6.18M | 7.04M | 9.01M | 10.53M | 10.66M | 11.79M | 12.14M | 12.17M | 12.29M | 12.27M | 11.57M | 11.44M | 10.42M |
Research & Development | 865.94K | 1.2M | 2.55M | 3.87M | 4.44M | 6.2M | 6.67M | 6.91M | 7.09M | 6.84M | 6.68M | 7.08M | 10.08M | 11.72M | 11.94M | 10.73M | 6.82M |
Other Expenses | 557K | 3.34K | -351.2K | -317.75K | -312.07K | 49.48K | 44.34K | 12.03K | 5.97K | 1.13K | 2.65K | 2.21K | 4.94K | 5.45K | 3.6K | 5.34K | 2.99K |
Operating Expenses | 7.07M | 5.75M | 6.69M | 8.2M | 10.62M | 13.24M | 15.68M | 17.45M | 17.76M | 18.62M | 18.83M | 19.25M | 22.38M | 23.98M | 27.86M | 26.52M | 21.59M |
Interest Expense | 846K | 908.94K | 1.04M | 1M | 1.12M | 1.52M | 7.87M | 7.51M | 7.13M | 6.59M | n/a | n/a | n/a | n/a | n/a | 715.00 | 58.08K |
Selling & Marketing Expenses | n/a | -9.74K | -14.23K | -14.23K | 154.99K | 363.84K | 635.47K | 875.33K | 1.01M | 950.42K | 823.54K | 713.89K | 544.33K | 542.59K | 523.36K | 491.19K | 444.49K |
Cost & Expenses | 7.07M | 5.75M | 6.7M | 8.21M | 11.64M | 15.53M | 19.06M | 22.1M | 22.5M | 22.93M | 23.26M | 23.39M | 26.34M | 28.32M | 33.73M | 32.32M | 27.28M |
Income Tax Expense | 2.16K | 3.91K | -6.42K | -4.22K | -41.19K | -206.75K | -473.21K | -703.97K | -660.35K | -495.84K | -221.31K | 10.47K | 5.63K | 5.43K | 5.05K | 6.34K | 6.33K |
Shares Outstanding (Basic) | 1.46K | 73.64 | 382K | 7.6M | 5.94M | 5.22M | 5.05M | 5.05M | 4.93M | 4.21M | 3.94M | 3.67M | 3.53M | 3.13M | 2.9M | 2.89M | 2.76M |
Shares Outstanding (Diluted) | 1.46K | 73.64 | 387.88K | 7.6M | 5.94M | 5.23M | 5.05M | 5.05M | 4.96M | 4.21M | 3.94M | 3.67M | 3.53M | 3.13M | 2.9M | 2.89M | 2.82M |
EPS (Basic) | -11.63K | -11.63K | -5.79 | -1.74 | -2.22 | -2.71 | -4.27 | -4.52 | -4.96 | -5.35 | -5.26 | -5.27 | -5.98 | -6.09 | -1.12 | -4.24 | -23.64 |
EPS (Diluted) | -11.63K | -11.63K | -5.72 | -1.74 | -2.22 | -2.71 | -4.26 | -4.51 | -4.95 | -5.34 | -5.26 | -5.27 | -5.98 | -6.06 | -1.09 | -4.21 | -23.61 |
EBITDA | -6.08M | -5.25M | -6.73M | -8.12M | -9.95M | -11.67M | -14.36M | -15.55M | -16.55M | -17.86M | -17.56M | -18.4M | -21.74M | -22.63M | -22.22M | -25.46M | -36.52M |
EBIT | -5.92M | -5.25M | -6.73M | -8.12M | -10.08M | -11.91M | -14.08M | -14.77M | -15.75M | -17.03M | -17.27M | -18.61M | -21.86M | -22.66M | -22.25M | -25.55M | -36.68M |
Depreciation & Amortization | 1.12K | 2.25K | 6.74K | -232.35K | -110.68K | 4.5K | 83.08K | 411.72K | 380.75K | 348.69K | 353.01K | 345.4K | 331.12K | 321.06K | 262.03K | 259.09K | 264.43K |